primary cutaneous T-cell non-Hodgkin lymphoma (Cancer)
Information
- Disease name
- primary cutaneous T-cell non-Hodgkin lymphoma
- Disease ID
- DOID:0060061
- Description
- "A non-Hodgkin's lymphoma that has_material_basis_in a mutation of T cells." [url:http\://en.wikipedia.org/wiki/Cutaneous_T-cell_lymphoma]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT04312841 | Active, not recruiting | Phase 2 | Letermovir for the Prevention of Cytomegalovirus Reactivation in Patients With Hematological Malignancies Treated With Alemtuzumab | September 15, 2020 | December 31, 2024 |
NCT01000753 | Completed | Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma | May 30, 2005 | September 30, 2023 | |
NCT04676087 | Recruiting | Phase 1/Phase 2 | Mogamulizumab and Extracorporeal Photopheresis for the Treatment of Sezary Syndrome or Mycosis Fungoides | April 21, 2021 | April 28, 2025 |
NCT04930653 | Recruiting | Phase 2 | Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma | October 19, 2022 | May 16, 2025 |
- Disase is a (Disease Ontology)
- DOID:0050749
- Cross Reference ID (Disease Ontology)
- GARD:6226
- Cross Reference ID (Disease Ontology)
- MESH:D016410
- Cross Reference ID (Disease Ontology)
- NCI:C3467
- Exact Synonym (Disease Ontology)
- cutaneous T cell lymphoma
- Exact Synonym (Disease Ontology)
- cutaneous T-cell lymphoma